ZoomInfo Grew Revenue Just 1.5% Amid $17M Share Selloff
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
Ways To Save Money While Studying
Learn various ways to save money while studying, helping you build your financial skills and enjoy a more manageable budget during college.
27,538 articlesXLK’s Quiet Edge Over FTEC Holds Steady Amid 2026 Markets
In 2026, XLK’s cap-driven approach has quietly outpaced FTEC. Concentration limits are redirecting capital toward sem...
Marvell Price Target Vaults Higher on AI Infra Momentum
Wells Fargo and Oppenheimer boosted Marvell targets this week, signaling rising confidence in AI infrastructure deman...
These Giants Have Been Dormant, Now They Surprise Investors
IBM and Oracle have quietly strengthened AI backlogs and earnings, setting up a potential late-2026 surprise as marke...
SpaceX IPO Sparks Hollywood-Style Future Vision for Markets
SpaceX outlines a bold public listing to finance lunar and Martian programs, as markets evaluate the risk of big loss...
Ethereum Crypto Influencer Game Shuts Down After Buzz Fades
Fantasy Top captivated Crypto Twitter with a fresh take on fantasy sports powered by blockchain. Now, after two years...
Boomers Embrace $100,000 Blue-Chip Value Portfolio Today
A fresh passively managed strategy centers on established dividend payers to deliver roughly $6,500 a year from a $10...
Trump Media Moves Over Bitcoin Bets and Massive Losses
A high-profile crypto exposure is more than a headline. This deep dive unpacks what trump media moves over Bitcoin be...
Former NASA Robotics Chief Warns America Builds Wrong Robots
A former NASA robotics chief warns that the U.S. is betting on spectacle over practical automation. The piece examine...
Why Poet Technologies Stock Plummeted This Week Explained
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
Two Distinct Growth Paths: Johnson & Johnson vs AbbVie
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
This Stock Been Called Overvalued: Bears Still Lose
Critics have labeled this stock as overvalued for years, yet its price action and earnings trajectory tell a differen...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status